1. Home
  2. FMS vs QXO Comparison

FMS vs QXO Comparison

Compare FMS & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fresenius Medical Care AG

FMS

Fresenius Medical Care AG

N/A

Current Price

$24.04

Market Cap

12.5B

Sector

Health Care

ML Signal

N/A

Logo QXO Inc.

QXO

QXO Inc.

HOLD

Current Price

$14.98

Market Cap

12.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMS
QXO
Founded
1996
1988
Country
Germany
United States
Employees
108165
7794
Industry
Misc Health and Biotechnology Services
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
12.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FMS
QXO
Price
$24.04
$14.98
Analyst Decision
Sell
Strong Buy
Analyst Count
2
14
Target Price
$30.00
$32.85
AVG Volume (30 Days)
579.5K
26.7M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
2.57%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$70.27
Revenue Next Year
$3.83
$38.75
P/E Ratio
$15.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.02
$13.82
52 Week High
$27.64
$27.61

Technical Indicators

Market Signals
Indicator
FMS
QXO
Relative Strength Index (RSI) 64.14 37.52
Support Level $22.47 N/A
Resistance Level $24.71 $18.28
Average True Range (ATR) 0.29 1.01
MACD 0.06 -0.21
Stochastic Oscillator 93.10 18.83

Price Performance

Historical Comparison
FMS
QXO

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

About QXO QXO Inc.

QXO Inc is a publicly traded distributor of building products in North America. The company is executing its plan to become the tech-enabled leader in the around $800 billion building products distribution industry and generate outsized value for its shareholders. The group expects to achieve its target of nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.

Share on Social Networks: